Navigation Links
Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness
Date:5/28/2008

DALLAS May 29, 2008 The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.

UT Southwestern Medical Center researchers are among the first to show that a technique called bioluminescence imaging (BLI) can be used to determine the effectiveness of cancer drugs that choke off a tumors blood supply.

The technique requires a substrate called luciferin to be added to the bloodstream, which carries it to cells throughout the body. When luciferin reaches cells that have been altered to carry the firefly gene, those cells emit light.

Some cancer drugs, however, work by cutting off the blood supply to tumor cells. Given that luciferin is delivered via the vasculature, the researchers set out to determine the kinetics of luciferin delivery and whether BLI techniques could be used to gauge the effectiveness of drugs that destroy blood vessels that feed tumors.

They tested their theory in mice bearing human breast-cancer tumors. Before being introduced to the animals, the tumor cells had been transfected with the firefly gene, which becomes part of the cells as they divide and grow just like genetically modified, herbicide-resistant food crops.

For the study, researchers used BLI to monitor light emissions from tumors following administration of the luciferin. While the mice didnt visibly glow, the researchers used special light-detecting equipment to observe strong correlations between the amount of light emitted and the size of the tumor as it grew. Detected light emission, however, was severely reduced after the vascular-disrupting drug was administered.

What weve done is offer proof-of-concept that BLI may be an effective and cheaper method to assess drug development and effectiveness, said Dr. Ralph Mason, professor of radiology, director of the UT Southwestern Cancer Imaging Center and senior author of the study. The technique is not intended to be used for imaging tumors or diagnosing cancer in humans, but it potentially allows us to do much more efficient pre-clinical experiments.

Dr. Mason stressed that light-emission kinetics depend heavily on tumor location.

The findings are available online and in a future issue of the Journal of the Federation of American Societies for Experimental Biology.

Although magnetic resonance imaging (MRI) remains the gold standard of medical imaging, BLI has its advantages. The noninvasive procedure allows detection of cell viability not accessible by MRI and is less costly, according to researchers at UT Southwestern.

Ultimately, the MRI is much more sophisticated and can do more, but BLI is very straight-forward, Dr. Mason said. Its perfect for evaluating new classes of drugs designed to cause acute vascular changes in tumors because the tests are inexpensive and easy to do.

Dr. Mason said its critically important to develop new chemotherapeutic drugs because existing therapies, when used on their own, are far from ideal. Were lacking the optimal drugs as demonstrated by the people who are not cured by chemotherapy, he said.

He said many existing drugs kill 99 percent of a tumor but allow a few cells to survive, giving the tumor an opportunity to grow back.

Therefore, you need to do a lot of tests to optimize dosing, optimize repeat delivery and probably optimize the co-administration of other, more traditional drugs or therapies, he said. BLI provides an opportunity to do those tests cheaply and efficiently.

Dr. Mason said a handful of faculty members spent several months and about $50,000 to build the BLI instrument they used to collect this data. The team needed the charge-coupled device to detect the light emitted by the cancer cells because the light is too weak for human eyes to see.

Dr. Mason said the device is essentially an astronomy kit.

When youre looking at the stars, youre trying to assess very weak light signals, he said. Were using the same type of instrument to access very weak light coming out of an animal. The difference is that here, we have a very sensitive camera instead of a telescope.


'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Monitoring blood flow helps improve prostate biopsies, Jefferson researchers report
2. U.S. Web Site Helps Consumers Compare Hospitals
3. New Anticoagulation Management Software Helps Clinics Enhance Efficiency and Improve Patient Safety
4. Nutritionist to the Stars Helps to Launch European Liquid Appetite Controller
5. Protein Helps ID Thyroid Cancer Nodules
6. Blood Test Helps Docs Assess Breast Cancer Treatment
7. New Supplement Helps Americans Eat Less Every Day
8. New Presidential $1 Coin Helps Highlight National Stroke Awareness Month This May
9. Salient Corporations Performance Management Solution Helps NY State Counties Identify Medicaid Fraud, Waste, and Abuse
10. Web Site Helps Patients Prepare for Hospital Stay
11. Computer Program Helps Drug Abusers Stay Clean
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to ... advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser ... of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... , ... The annual time frame to change Medicare health and prescription drug ... 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to ... make changes during this period order for their new policy to go into effect ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
(Date:12/2/2016)... December 2, 2016 - bioLytical lanza el INSTI HIV ... la OMS     Continue Reading ... ... , , bioLytical ... anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV Self Test ...
(Date:12/2/2016)... December 2, 2016 According to the ... Market Study on Automated Endoscope Reprocessors: Single Basin Automated Endoscope ... 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors market was ... to expand at a CAGR of 7.2% during an eight-year ... 1,367.6 Mn by 2024. ...
Breaking Medicine Technology: